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High on Life? Medical Marijuana Laws and Suicide 
 
Using state-level data for the period 1990 through 2007, we estimate the effect of legalizing 
medical marijuana on suicide rates. Our results suggest that the passage of a medical 
marijuana law is associated with an almost 5 percent reduction in the total suicide rate, an 11 
percent reduction in the suicide rate of 20- through 29-year-old males, and a 9 percent 
reduction in the suicide rate of 30- through 39-year-old males. Estimates of the relationship 
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1. INTRODUCTION 
  Under the Controlled Substances Act of 1970, marijuana was classified as a 
Schedule I drug because it was considered to have no “accepted medical use in treatment 
in the United States” (Eddy 2010).  Since then, 16 states and the District of Columbia 
have legalized the use of medical marijuana; six more state legislatures have recently 
considered medical marijuana bills. 
The relationship between marijuana and mental health has received a great deal of 
attention from both proponents and opponents of legalization.  Proponents argue that 
marijuana can be an effective treatment for bipolarism, depression, and other mood 
disorders (Rosenthal et al. 1996; Grinspoon and Bakalar 1997; Zimmerman 1999).
1  They 
also argue that medical marijuana patients are able to reduce their use of pain killers, 
tranquilizers, and psychiatric medicines because of marijuana (Lucido 2004).
2  
Opponents, on the other hand, argue that marijuana use increases the likelihood of 
depression, anxiety, psychosis, and schizophrenia (Zammit et al. 2002; Henquet et al. 
2004; Goldberg 2006; Shulman 2008).  They also argue that the negative effects of 
marijuana are long-lasting and that users are at risk of suffering from decreased 
psychological well-being later in life (Green and Ritter 2000; McGee et al. 2000).   
  This paper examines the relationship between medical marijuana laws (hereafter 
MMLs) and suicides.  While the majority of people who suffer from mental illness do not 
commit suicide, over 90 percent of those who do commit suicide have a diagnosable 
mental or substance use disorder (Moscicki 2001).  The relationship between marijuana 
                                                 
1 Tetrahydrocannabinol (THC), the primary psychoactive ingredient in marijuana, produces mild euphoria 
and has analgesic effects (Elphick and Egertova 2001). 
 
2 Among some advocates, marijuana is referred to as “green Prozac” (Chaboya-Hembree 2011).   2 
use and suicide-related outcomes (e.g., depression, suicidal ideation, and suicide 
attempts) has been studied extensively (Petronis et al. 1990; Felts et al. 1992; Borowsky 
et al. 2001), but there have been no previous attempts to estimate the effect of medical 
marijuana laws on completed suicides, the tenth leading cause of death in the United 
States (National Institute of Mental Health 2010). 
  This study begins by detailing the channels through which MMLs could impact 
the risk of suicide.  We cite research from epidemiological and medical studies showing 
that marijuana use is associated with depression and suicidal ideation, although we note 
that any observed association between marijuana use and outcomes such as these could 
be driven by difficult-to-observe factors (Van Ours and Williams 2011) or simply reflect 
self-medication (Gruber et al. 1996; Rey et al. 2002).  We also note that previous studies 
have found evidence to support the hypothesis that marijuana and alcohol are substitutes 
(Chaloupka and Laixuthai 1997; Saffer and Chaloupka 1999; DiNardo and Lemieux 
2001; Anderson et al. 2011; Crost and Guerrero 2011), and cite research linking alcohol 
policies and suicides (Birckmayer and Hemenway 1990; Jones et al. 1992; Markowitz et 
al. 2003; Carpenter 2004; Carpenter and Dobkin 2009).  
The empirical analysis draws on data from the Centers for Disease Control from 
1990 through 2007 to estimate the effect of legalization on suicide rates.  Our results 
suggest that the passage of a MML is associated with an almost 5 percent reduction in the 
total suicide rate.   
When we examine the relationship between legalization and suicides by gender 
and age, we find evidence that MMLs are associated with decreased suicides among 20- 
through 29-year-old males and among 30- through 39-year-old males.  This result is   3 
consistent with registry data from Arizona, Colorado, and Montana showing that most 
medical marijuana patients are male, and that roughly half are under the age of 40 
(Anderson et al. 2011).  Estimates of the relationship between legalization and suicides 
among females are less precise, and are sensitive to functional form.  We conclude that 
the legalization of medical marijuana leads to an improvement in the psychological well- 
being of young adult males, an improvement that is reflected in fewer suicides.   
 
2. BACKGROUND 
2.1. MMLs and substance use 
MMLs remove criminal penalties for using, possessing, and cultivating marijuana 
for medicinal purposes.  Because it is prohibitively expensive for the government to 
ensure that all marijuana ostensibly grown for the medicinal market ends up in the hands 
of registered patients, diversion to the illegal market likely occurs.
3  Only a handful of 
MMLs permit individuals with mental health problems to obtain medical marijuana.  
California includes anxiety as a qualifying condition, while Delaware and New Mexico 
both allow the use of medical marijuana for post traumatic stress disorder (Marijuana 
Doctors 2011).  However, without exception, MMLs allow patients to register based on 
medical conditions that cannot be objectively confirmed (e.g., chronic pain and nausea), 
and in some states it is possible to petition for access to medical marijuana based on 
ailments not included on the official list of qualifying conditions (Marijuana Doctors 
2011). 
                                                 
3 All MMLs enacted during the period 1990-2007 allowed for home cultivation.  Since 2007, Delaware, 
New Jersey and Washington D.C. have passed MMLs that do not permit home cultivation (Marijuana 
Policy Project 2011). 
   4 
 
Surprisingly little is known about the relationship between MMLs and marijuana 
use.  Gorman and Huber (2007) examined data on adult arrestees for the period 1995–
2002 from Denver, Los Angeles, Portland, San Diego and San Jose.  They found little 
evidence that marijuana use by arrestees increased as a result of legalization.  In contrast, 
Wall et al. (2011) found that rates of marijuana use among 12- through 17-year-olds were 
higher in states that had legalized medical marijuana than in states that had not, but noted 
that “in the years prior to MML passage, there was already a higher prevalence of use and 
lower perceptions of risk” in states that had legalized medical marijuana. 
Perhaps the best evidence on the relationship between MMLs and marijuana use 
comes from Anderson et al. (2011).  These authors used a difference-in-differences 
estimation strategy and data from the National Survey on Drug Use and Health (NSDUH) 
from three states that legalized medical marijuana in the mid-2000s: Montana, Rhode 
Island, and Vermont.  They found that marijuana use among 18- through 25-year-olds 
living in Montana increased by 19 percent as a result of legalization.  Marijuana use 
among 18- through 25-year-olds living in Rhode Island increased by 21 percent, and 
marijuana use by Rhode Island residents ages 26 and older increased by 44 percent.  
However, there was no evidence that legalization in Vermont led to an increase in 
consumption.
4  
Anderson et al. (2011) also examined the relationship between MMLs and alcohol 
consumption.  Using data from the Fatal Accident Report System (FARS) for the period 
1990-2009, they found that legalization of medical marijuana led to a sharp reduction in 
                                                 
4 Vermont passed a MML in 2004, but did not allow for medical marijuana dispensaries until 2011.  This 
likely explains Anderson et al.’s (2011) null finding for Vermont. 
   5 
fatal crashes involving alcohol.  In addition, using data from the Behavioral Risk Factor 
Surveillance System (BRFSS) for the same period, they found evidence that legalization 
led to a 25 percent reduction in self-reported alcohol consumption among 20- through 29-
year-olds; using data from the Beer Institute, they found that legalization led to a 5.3 
percent decrease in per capita beer sales, the most popular alcoholic beverage among 
young adults (Jones 2008).
5  Anderson et al. (2011) concluded that their results were 
“consistent with the hypothesis that marijuana and alcohol are substitutes” (p. 18).
6   
 
2.2. Stressful life events and suicide 
Hamermesh and Soss (1974) were the first economists to model suicidal behavior. 
According to their “economic theory of suicide”, negative shocks to happiness can reduce 
expected lifetime utility to the point where an individual will decide to take his or her 
own life.  Even if a shock is perceived to be temporary, an individual with “time-
inconsistent preferences” may commit suicide at the prospect of having to cope with an 
acutely “painful state in the present” (Cutler et al. 2001, p. 235).
7   
In fact, there is evidence that suicide among adolescents and young adults is often 
triggered by “stressful life events”, or SLEs.  SLEs include the breakup of a romantic 
                                                 
5 Estimates from Anderson et al. (2011) on the relationship between MMLs and alcohol consumption are 
reproduced in Appendix Tables 2 and 3.   
 
6 Anderson et al. (2011) noted that a consensus has not been reached with regard to the relationship 
between marijuana and alcohol consumption.  A number of studies have found evidence of 
complementarity between marijuana and alcohol (Pacula 1998; Farrelly et al. 1999; Williams et al. 2004; 
Yörük and Yörük 2011), while others studies lend support to the hypothesis that marijuana and alcohol are 
substitutes (Chaloupka and Laixuthai 1997; Saffer and Chaloupka 1999; DiNardo and Lemieux 2001; Crost 
and Guerrero 2011).   
 
7 There is evidence to support the hypothesis that preferences are time inconsistent (O’Donoghue and Rabin 
2001, p. 41).  Non-economists have exerted considerable effort to understand the rationality (or lack 
thereof) of suicide.  See, for instance, Henry and Short (1954), Brandt (1975) and Graber (1981).    6 
relationship (De Wilde et al. 1992; Brent et al. 1993; Beautrais et al. 1997; Johnson et al. 
2002), conflict with a parent or sibling (Brent et al. 1993; Johnson et al. 2002), an 
abortion (Gissler, Hemminki, and Lonnqvist 1996; Gissler et al. 2005), and 
legal/disciplinary problems (Brent et al. 1993).   
Among older adults, problems at work, financial difficulties, unemployment and 
separation/divorce are common triggers of suicide (Heikkinen et al. 1994; Johansson and 
Sundquist 1997; Cavanagh et al. 1999; Preti and Miotto1999; Duberstein et al. 2004; 
Kõlves et al. 2006).  Among the elderly, suicide is often associated with physical illness 
and functional impairment (Whitlock 1986; Mackenzie and Popkin 1987; Harris and 
Barraclough 1994; Conwell et al 2000; Waern et al. 2002).  A number of researchers 
have concluded that the symptoms of depression (or self-reported depression) mediate the 
relationship between SLEs and suicidal behavior (Fergusson et al. 2000; Conwell et al. 
2002; Hardt and Johnson 2010).  
 
2.3. Marijuana use and mental health 
Could marijuana use help individuals cope with the negative shocks to happiness 
that, according to Hamermesh and Soss (1974), lead to suicide?  Alternatively, could 
marijuana use magnify the impact of SLEs?   
Animal studies provide evidence that, at low doses, synthetic cannabinoid 
injections can have a potent anti-depressant effect (Jiang et al. 2005; Bambico et al.   7 
2007).  However, higher dosages can reduce serotonin transmission and lead to 
“depression-like behavior” (Bambico et al. 2007; Bambico et al. 2010).
8  
The majority of epidemiological studies have found that marijuana use is 
positively associated with both the symptoms of depression and suicidal ideation (Rey et 
al. 2002; Moore et al. 2007).
9  However, any association between marijuana use and 
outcomes such as these could be driven by difficult-to-observe factors (Van Ours and 
Williams 2011) or simply reflect self-medication (Gruber et al. 1996; Rey et al. 2002).  
Although there have been attempts to account for these sources of endogeneity, none 
have been particularly convincing.  Moore et al. (2007, p. 325) concluded their review of 
the literature by noting that “the majority of studies for affective outcomes [such as 
depression and suicidal ideation] did not adequately address the problem of reverse 
causation as a possible alternative explanation for any association observed.”   
 
2.4. Alcohol use and mental health 
  Alcohol consumption represents an alternative route through which legalization of 
medical marijuana could impact suicides.  Numerous studies have shown that alcoholism 
is more common among individuals with major depression (Sullivan et al. 2004).  
                                                 
8 Deficiency of the neurotransmitter serotonin, a chemical produced by the brain, is linked to depression 
(Karg et al. 2011). 
 
9 For instance, Bovasso (2001) found that marijuana use was positively associated with these outcomes 
among Baltimore residents who participated in the Epidemiologic Catchment Area Study; Fergusson et al. 
(2002) found similar results among teenagers and young adults in New Zealand.  In contrast, Denson and 
Earleywine (2006) found a negative association between marijuana use and the symptoms of depression.  
Beautrais et al. (1999) found that “much of the association between cannabis abuse/dependence and suicide 
attempt risk arose because: (a) individuals who develop cannabis abuse/dependency tend to come from 
disadvantaged socio-demographic and childhood backgrounds…, or (b) because cannabis 
abuse/dependence is co-morbid with other mental disorders which are independently associated with 
suicidal behaviour.”  Moore (2007) described the case of one woman who “without the relief that marijuana 
delivered to her…killed herself at home”.  
 
   8 
Moreover, alcoholism is associated with suicidal ideation as well as attempted and 
completed suicides (Cornelious et al. 1995; Kessing 1999; Chatterji et al. 2004; 
Rodriguez Andres 2005). 
  Policy studies provide further evidence of a link between alcohol use and suicide.  
For instance, Birckmayer and Hemenway (1990) and Carpenter and Dobkin (2009) 
provide evidence that prohibiting young adults from drinking protects against suicide.  In 
a similar vein, Carpenter (2004) found that the adoption of stricter drunk driving laws 
lead to fewer suicides among young males.  Markowitz et al. (2003) found a strong 
negative relationship between the excise tax on beer and male suicides.
 10  Interestingly, 
neither Carpenter (2004) nor Markowitz et al. (2003) found consistent evidence that 
alcohol policies had an impact on female suicides.  
 
3. SUICIDE, TRENDS AND DATA  
  Data on suicides come from the National Center for Health Statistics Mortality 
Detail Files, produced by the Centers for Disease Control.
11  Table 1 shows the number 
of suicides per 100,000 population by age and gender for the period under study, 1990-
2007. 
  Females suffer from depression and attempt suicide at higher rates than males 
(Murphy 1998).
12  Nevertheless, males are approximately four times more likely to 
                                                 
10 See also Son and Topyan (2011), who examined the relationship between alcoholic beverage excise taxes 
and suicides using data from the United States for the period 1995-2004.  
 
11 As pointed out by Birckmayer and Hemenway (1999) and Carpenter (2004), suicides are likely 
underreported in these data.  However, there is no reason to believe that this underreporting is 
systematically related to the legalization of medical marijuana. 
 
12 Murphy (1998) argued that females are less likely to commit suicide than males because they are more 
likely to seek treatment for depression.   9 
commit suicide.  Since 1990, the male suicide rate has decreased slightly, while the 
female suicide rate has remained fairly constant (Figure 1).   
Fifteen- through 19-year-olds were less likely to commit suicide than older 
individuals during the period under study; males over the age of 59 were the most likely 
to commit suicide (Figures 2 and 3).  Canetto (1992) argued that, as they age, men are 
especially prone to suicide because they have unrealistic expectations and an inadequate 
range of coping strategies. Clarke (1993, p. 21) hypothesized that “elderly persons who 
die by suicide have a lifelong character fault that remains invisible until aging life-
changes force the issue into the open.”   
  Figures 4 through 14 illustrate suicide trends by legalization status.
13  For states 
that legalized medical marijuana, we report the suicide rate for the three years prior to 
legalization, the year in which the law changed (year 0), and the three years following 
legalization.  For states that did not legalize medical marijuana during the period under 
study, the year in which the law changed was randomly assigned. 
  Figure 4 presents pre- and post-legalization trends in the total suicide rate.  The 
total suicide rate falls smoothly during the pre-legalization period in both MML and non-
MML states.  However, beginning in year 0, the trends diverge: the suicide rate in MML 
states continues to fall, while the suicide rate in states that never legalized medical 
marijuana begins to climb gradually.  Comparing Figures 5 and 6, it is clear that the post-
legalization downward trend in male suicides is much more pronounced than the post-
legalization downward trend in female suicides. 
                                                 
13 In each figure, a vertical line separates the years before legalization from the year of the law change and 
the post- legalization period.   10 
  Consistent with the hypothesis that marijuana can be an effective treatment for 
depression and other mood disorders, there appears to be a sharp decrease in the suicide 
rate of 15- through 19-year olds males in the treatment states as compared to the control 
states approximately two years after legalization (Figure 7).  A similar decrease can be 
seen for 20- through 59-year-old males (Figures 8 and 9), and there is a modest decrease 
in the suicide rate of males 60 years of age and older approximately three years after 
legalization (Figure 10).  Among females under the age of 40, there is little evidence that 
legalization lead to a decrease in the suicide rate (Figures 11 and 12).  However, among 
older females, there appears to be a small decrease in the suicide rate two to three years 
after legalization (Figures 13 and 14). 
 
 
4. THE EMPIRICAL MODEL  
  The trends discussed above could be driven by a number of factors such as state- 
level economic conditions or alcohol policies.  In order to address this shortcoming, we 
use a difference-in-differences (DD) regression framework to estimate the relationship 
between MMLs and suicide rates.  This framework allows us to control for both 
unobserved state-level heterogeneity and national trends.  Our baseline estimating 
equation is: 
 
(1)    ln(Suicides Totalst) = β0 + β1MMLst + Xstβ2 + vs + wt + εst, 
 
where s indexes states, t indexes years, and vs and wt represent state and year fixed 
effects, respectively.  The variable MMLst is an indicator for whether medical marijuana   11 
was legal in state s and year t.  The coefficient of interest, β1, represents the effect of 
medical marijuana legislation.  In alternative specifications we replace Suicides Totalst 
with the other dependent variables listed in Table 1 and add state-specific linear time 
trends to the right-hand side.
14  The state-specific trends are intended to control for the 
influence of difficult-to-measure factors at the state level that evolve smoothly over time 
such as attitudes.
15     
  The vector Xst includes indicators for whether Zero Tolerance drunk driving and 
0.08 BAC laws were enforced in state s and year t, and the state beer tax.  Previous 
studies provide evidence that stricter alcohol policies and higher beer taxes can reduce 
suicides (e.g., Jones et al. 1992; Birckmayer and Hemenway 1999; Markowitz et al. 
2003; Carpenter 2004).
16  In addition, the vector Xst includes the state unemployment rate 
and income per capita.
17  Previous studies have shown that suicide rates are sensitive to 
economic conditions (Gerdtham and Johannesson 2003; Andres 2005; Minoiu and 
Rodriguez Andres 2008; Chung 2009).  Finally, we control for whether marijuana use 
and possession was decriminalized.
18 
                                                 
14 In other words, we include an interaction between the state dummies and a variable equal to 1 in 1990, 2 
in 1991, 3 in 1993, and so forth. 
 
15 DeCicca et al. (2008) found that attitudes toward cigarette smoking were an important determinant of 
youth smoking participation. 
 
16 Data on the Zero Tolerance laws, 0.08 BAC laws, and beer taxes are from the National Highway Traffic 
Safety Administration, Freeman (2007), and the Beer Institute, respectively.  Jones et al. (1992) and 
Birckmayer and Hemenway (1999) both found that higher minimum legal drinking ages (MLDA) were 
associated with fewer youth suicides.  Carpenter and Dobkin (2009) used a regression discontinuity design 
to show that granting legal access to alcohol at age 21 leads to a large and immediate increase in suicides.  
But, because all states had a minimum legal drinking age of 21 by 1990, we do not control for the MLDA. 
 
17 The unemployment and income data are from the Bureau of Labor Statistics and the Bureau of Economic 
Analysis, respectively. 
 
18 During the period 1990-2007, the decriminalization indicator only captures one policy change:  Nevada 
decriminalized marijuana in 2001.  The majority of these laws were passed prior to 1990.   12 
5. THE RESULTS 
5.1. The baseline results 
Table 2 presents OLS estimates of the relationship between MMLs and suicides.  
All regressions are weighted by the relevant population in state s and year t, and the 
standard errors are corrected for clustering at the state level (Bertrand et al. 2004). 
The estimated relationship between MMLs and the total suicide rate is presented 
in the first column of Table 2.  Controlling for year and state fixed effects, the 
legalization of medical marijuana is associated with an 8.1 percent decrease in the suicide 
rate (e
-0.084 – 1 = -0.081).  When the controls listed in Table 1 are included, legalization is 
associated with a 6.9 percent decrease in the suicide rate; when state-specific linear time 
trends are included, legalization is associated with a 4.8 percent decrease in the suicide 
rate. 
  In the remaining columns of Table 2, we allow the estimated relationship between 
legalization and suicides to differ by gender.  MMLs are associated with a 4.6 to 7.0 
percent decrease in the male suicide rate.  MMLs are negatively associated with the 
female suicide rate, but these estimates are not statistically significant at conventional 
levels.      
 
5.2. Estimates by gender and age group 
  Next, we examine the relationship between the legalization of medical marijuana 
and suicides by age group (Table 3).  Our estimates suggest that legalization leads to a 
sharp reduction in suicides among young adult males.  For instance, in the fully-specified 
model, legalization is associated with a 10.8 percent decrease in the suicide rate of 20- 
through 29-year-old males, and a 9.4 percent decrease in the suicide rate of 30- through   13 
39-year-old males.  These results are consistent with those of Anderson et al. (2011), who 
found that MMLs have the greatest impact on the substance use of young adults, and are 
also consistent with registry data from Arizona, Colorado, and Montana showing that 
most medical marijuana patients are male and that roughly half of medical marijuana 
patients are under the age of 40 (Anderson et al. 2011).   
Although the estimates of β1 are negative for males between the ages of 15 and 
19, they are never significantly different from zero.  Likewise, the estimates of β1 for 
males ages 40 through 59 are consistently negative, but not precisely estimated.  For 
males 60 years of age and older, estimates are negative in two of the three specifications, 
but none are precisely estimated. 
Table 4 presents the results for females by age group.  There is little evidence that 
legalization of medical marijuana impacted suicides among females under the age of 30.  
The estimated relationship between legalization and suicides is stronger among older 
females, although it is sensitive to model specification.  Controlling for state and year 
fixed effects and the covariates listed in Table 1, the legalization of medical marijuana is 
associated with a 10.4 percent decrease in the suicide rate of 30- through 39-year-old 
females.  However, the estimated impact of legalization becomes much smaller in 
magnitude and is no longer statistically significant when we add state-specific linear time 
trends.   
Although consistently negative, the estimated impact of legalization for females 
ages 40 through 49 is never statistically significant.  However, when we control for state-
specific linear time trends, legalization is associated with large and statistically   14 
significant decreases in the suicide rate of 50-through 59-year-old females and the suicide 
rate of females ages 60 and older. 
 
5.3. Adding leads and lags to the model 
  In Table 5 we examine pre- and post-legalization trends in suicides using the 
regression framework introduced above.  Specifically, we include three lead indicators, 
an indicator for the year of the law change, and four lag indictors.  The omitted category 
is 3+ years before a MML was passed.    
  The results are consistent with the hypothesis that MMLs have a causal impact on 
male suicide rates.  Controlling for year and state fixed effects, the covariates listed in 
Table 1 and state-specific linear trends, none of the lead dummies are statistically 
distinguishable from zero.  However, once a MML is passed, there is a strong negative 
relationship between legalization and the male suicide rate.   
  In contrast, the evidence that legalization reduces suicides among females is much 
weaker.  The estimated coefficients of the three lead indicators are large, negative, and 
statistically significant, suggesting that there was a systematic change in the suicidal 
behavior of females preceding legalization.   Although the estimated coefficients of the 
lag indicators are two to three times larger than those of the lead indicators, we cannot 
reject the hypothesis that they are equal.
19   
 
5.4. A placebo test 
                                                 
19 As noted above, Carpenter (2004) found evidence that Zero Tolerance drunk driving laws were 
negatively associated with male suicides.  He also found evidence of an implausibly large (and statistically 
significant) relationship between Zero Tolerance drunk driving laws and female suicides. 
   15 
  Lastly, we performed a robustness check based on Luallen (2006).
20  Specifically, 
we generated a placebo MML indicator using a random number generator based on the 
continuous uniform distribution.  Because 12 states passed a MML during our sample 
period, we assigned 12 placebo policies for each trail run.
21  In total, 50 trials were run.    
Table 6 illustrates the average coefficient estimates for the placebo MML on total, 
male and female suicide rates.  In all three sets of regressions, the average estimate is 
quite small in magnitude.   Moreover, in 50 trials, only four estimates were negative and 
statistically significant at the 5 percent level for the total suicide rate.   For male and 
female suicide rates, only three and four of the estimates were negative and statistically 
significant at the 5 percent level, respectively.  This pattern of results provides evidence 





Numerous epidemiological studies have found a positive association between 
marijuana and suicide-related outcomes such as depression and suicidal ideation.  
However, this association could be driven by difficult-to-observe factors or simply reflect 
self-medication.  In fact, a recent review of the epidemiological literature concluded that 
most studies had not adequately addressed the problem of reverse causation (Moore et al. 
2007). 
 
                                                 
20 Luallen (2006) examined the relationship between teacher strike days and juvenile crime. 
 
21 A year of legalization between 1990 and 2007 was randomly selected.  Randomly assigning a 
legalization year between 1999 and 2007 produced qualitatively similar results.     16 
The current study avoids the problems of reverse causality and unobserved 
heterogeneity at the individual level by examining the relationship between the 
legalization of medical marijuana and completed suicides.  Specifically, we use a 
difference-in-differences empirical strategy to estimate the impact of MMLs on state-
level suicide rates.  Our results suggest that the legalization of medical marijuana is 
associated with a 5 percent decrease in the total suicide rate, an 11 percent decrease in the 
suicide rate of 20- through 29-year-old males, and a 9 percent decrease in the suicide rate 
of 30- through 39 year-old-males.  Estimates for female suicide rates are generally 
measured with less precision and are sensitive to functional form. 
In an often-cited article, Hamermesh and Soss (1974) argued that negative shocks 
to happiness may reduce expected lifetime utility to the point where an individual will 
decide to take his or her own life.  The negative relationship between legalization and 
suicides among young adult males is consistent with the argument that marijuana can be 
used to cope with such shocks.  However, estimates provided by Anderson et al. (2011) 
provide an alternative explanation.  These authors found that the passage of MMLs led to 
sharp decreases in alcohol-related traffic fatalities, self-reported alcohol use, and per 
capita beer sales.  The strong association between alcohol consumption and suicide-
related outcomes found by previous researchers (Markowitz et al. 2003; Carpenter 2004; 
Sullivan et al. 2004; Rodriguez Andres 2005; Carpenter and Dobkin 2009) raises the 
possibility that medical marijuana laws reduce the risk of suicide by decreasing alcohol 
consumption. 
Although 16 states have passed medical marijuana laws, and others are 
considering legalization, very little is known about the effects of these laws.    17 
Policymakers weighing the pros and cons of legalization should consider the possibility 
that medical marijuana laws may lead to fewer suicides among young adult males.  
However, the exact mechanism through which suicides are reduced remains a topic for 
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Figure 1. National Suicide Rates 
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Figure 2. National Suicide Rates by Age, Males 
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Figure 3. National Suicide Rates by Age, Females 
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
Figure 7. Pre- and Post-Legalization Trends in Suicide Rates,  
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
Figure 8. Pre- and Post-Legalization Trends in Suicide Rates,  
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
Figure 9. Pre- and Post-Legalization Trends in Suicide Rates,  
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
Figure 10. Pre- and Post-Legalization Trends in Suicide Rates,  
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
Figure 11. Pre- and Post-Legalization Trends in Suicide Rates,  
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
Figure 12. Pre- and Post-Legalization Trends in Suicide Rates,  
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On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical 
marijuana during the period under study (1990-2007). 
Figure 13. Pre- and Post-Legalization Trends in Suicide Rates,  
















-3  -2  -1  Year of 
law 
change 



























On the horizontal axis, 0 represents the year in which medical marijuana was 
legalized.  It was randomly assigned to states that did not legalize medical marijuana 
during the period under study (1990-2007). 
Figure 14. Pre- and Post-Legalization Trends in Suicide Rates,  
Females 60+ years-old 
MML 
Non-MML  
Table 1. Weighted Means of Dependent and Independent Variables 
                 
Dependent Variables                                              Mean (SD) 
 
Suicide rates per 100,000 
 
Suicides Total           14.3 (3.47) 
 
Suicides Male           23.7 (5.72) 
   Ages 15-19            14.4 (6.13) 
   Ages 20-29            22.9 (6.92) 
   Ages 30-39            22.9 (6.27) 
   Ages 40-49            24.0 (6.19) 
   Ages 50-59            23.3 (6.10) 
   Ages 60+            30.3 (8.81) 
 
Suicides Female          5.51 (1.49) 
   Ages 15-19            3.09 (1.82) 
   Ages 20-29            4.13 (1.53) 
   Ages 30-39            5.79 (2.00) 
   Ages 40-49            7.35 (2.59) 
   Ages 50-59            6.97 (2.43) 




Medical Marijuana Law        0.111 (0.311) 
Marijuana Decriminalization Law      0.327 (0.469) 
Ln (State Income)          10.3 (0.153) 
Unemployment Rate          5.43 (1.36) 
Blood Alcohol Content 0.08        0.509 (0.491) 
Zero Tolerance Law          0.721 (0.440) 
Real Beer Tax (2000 dollars)       0.252 (0.214) 
 
N                                918       
  
Table 2. Estimates of Relationship between Medical Marijuana Laws and the 
Natural Log of the Suicide Rate 


























































Observations  918  918  918 
 
***Statistically significant at the 1% level; **at the 5% level; *at the 1% level. 
 
Each cell represents the results from a separate regression.  The dependent variable is equal to the 
natural log of the suicide rate per 100,000 population, and is based on information collected from 
the Centers for Disease Control for the period 1990-2007; the covariates are listed in Table 1.  
Regressions are weighted using the relevant state-by-sex populations.  Standard errors, corrected 
for clustering at the state level, are in parentheses and R
2s are in brackets. 
  
Table 3. Estimates of Relationship between Medical Marijuana Laws and the 
Natural Log of the Male Suicide Rate by Age Group 














































































































Observations  918  918  918  918  918  918 
 
***Statistically significant at the 1% level; **at the 5% level; *at the 1% level. 
 
Each cell represents the results from a separate regression.  The dependent variable is equal to the natural log 
of the suicide rate per 100,000 population, and is based on information collected from the Centers for Disease 
Control for the period 1990-2007; the covariates are listed in Table 1.  Regressions are weighted using the 
relevant state-by-age populations.  Standard errors, corrected for clustering at the state level, are in parentheses 
and R
2s are in brackets. 
  
Table 4. Estimates of Relationship between Medical Marijuana Laws and the 
Natural Log of the Female Suicide Rate by Age Group 









































































































Observations  918  918  918  918  918  918 
 
 ***Statistically significant at the 1% level; **at the 5% level; *at the 1% level. 
 
Each cell represents the results from a separate regression.  The dependent variable is equal to the natural log of 
the suicide rate per 100,000 population, and is based on information collected from the Centers for Disease 
Control for the period 1990-2007; the covariates are listed in Table 1.  Regressions are weighted using the 
relevant state-by-age populations.  Standard errors, corrected for clustering at the state level, are in parentheses 
and R





















Table 5. Estimates of Relationship between Medical Marijuana Laws and the 
Natural Log of the Suicide Rate: Adding Leads and Lags to the Model 





















































































































Year FE  yes  yes  yes 
State FE  yes  yes  yes 
Covariates  yes  yes  yes 
State Trends  yes  yes  yes 
R
2  0.97  0.96  0.87 
Observations  918  918  918 
 
***Statistically significant at the 1% level; **at the 5% level; *at the 1% level. 
 
Each cell represents the results from a separate regression.  The dependent variable is equal to the 
natural log of the suicide rate per 100,000 population, and is based on information collected from 
the Centers for Disease Control for the period 1990-2007; the covariates are listed in Table 1.  
Regressions are weighted using the relevant state-by-sex populations.  Standard errors, corrected 
for clustering at the state level, are in parentheses and R
2s are in brackets. 
  
Table 6: The Average Effect of Randomly Assigned MMLs on Suicide Rates 
                   
        Suicides Total           Suicides Male           Suicides Female 
Average MML estimate        -0.002             -0.001    -0.009 
              (0.020)       (0.017)    (0.038) 
 
Number of trials              50           50         50 
 
Number of negative MML            30           29                   31 
coefficients 
 
Number of MML estimates    4             3           4 
that were negative and        
significant at 5% level         
 
Year FE                Yes           Yes       Yes 
State FE                Yes           Yes       Yes 
Covariates                 Yes           Yes       Yes 
State Trends                Yes           Yes       Yes 
 
*Statistically significant at 10% level; ** at 5% level; *** at 1% level. 
 
Notes:  Each column represents the results from a series of regressions.  Average standard errors, corrected 






















    
                  Appendix Table 1.  Medical Marijuana Laws, 1990-2007          
 
                  Effective date    
Alaska                 March 4, 1999 
California                November 6, 1996 
Colorado                June 1, 2001 
Hawaii                 December 28, 2000 
Maine                 December 22, 1999 
Montana                 November 2, 2004 
Nevada                October 1, 2001 
New Mexico                July 1, 2007 
Oregon                December 3, 1998 
Rhode Island                January 3, 2006 
Vermont                July 1, 2004 
Washington                November 3, 1998   
 
Notes:  Arizona, D.C., Delaware, Michigan, and New Jersey have passed medical marijuana laws since 
2007.  Source: Eddy (2010). 
   Appendix Table 2. Alcohol Consumption and Medical Marijuana Laws: Summary of Results from Anderson et al. (2011)    
             (1)      (2)      (3)      (4)      (5)      (6) 
          18-19    20-29    30-39    40-49    50-59    60 + 
          yr.-olds  yr.-olds  yr.-olds  yr.-olds  yr.-olds  yr.-olds     
Number of Drinks (Males) 
MML          -18.7%   -21.6%
**  -2.53%   -4.70%   -3.74%   -3.07% 
 
Observations        852    852    852    852    852    852     
Number of Drinks (Females) 
MML          5.26%   -21.0%
**  -10.3%
*  -12.6%
**  -5.43%   -12.2% 
 
Observations        855    855    855    855    855    855     
 
Year FE        Yes    Yes    Yes    Yes    Yes    Yes 
State FE        Yes    Yes    Yes    Yes    Yes    Yes 
Covariates        Yes    Yes    Yes    Yes    Yes    Yes 
State-specific trends      Yes    Yes    Yes    Yes    Yes    Yes       
 
*Statistically significant at 10% level; **at 5% level; ***at 1% level. 
 
Notes:  Each column represents the results from a separate regression.  The dependent variable is the mean number of drinks consumed in the past 30 days in 
state s and year t, and is based on information collected from the Behavioral Risk Factor Surveillance System (BRFSS) for the period 1990-2009.  Controls 
include the state unemployment rate, per capita income, the relevant population size (e.g., the number of males or females in state s and year t), the state beer tax, 
and indicators for marijuana decriminalization, BAC 0.08, administrative license revocation, and Zero Tolerance.  Regressions are weighted using sample sizes 








     Appendix Table 3. Alcohol Sales and Medical Marijuana Laws: Summary of    
             Results from Anderson et al. (2011)         
            (1)         (2)         (3) 
                                           State-level per           State-level per           State-level per   
           capita beer sales         capita wine sales       capita spirits sales 
             (1990-2009)           (1994-2009)          (1994-2009)   
 
MML               -5.3%***             -1.2%               -0.2% 
 
Observations               1020      816      816 
 
Year FE               Yes      Yes      Yes 
State FE               Yes      Yes      Yes 
State covariates             Yes      Yes      Yes 
State-specific trends             Yes      Yes      Yes     
 
*Statistically significant at 10% level; **at 5% level; ***at 1% level. 
 
Notes:  Each column represents the results from a separate regression.  The dependent variable is equal to 
the natural log of per capita sales (measured in gallons) and is based on data from the Brewers Almanac, 
published by the Beer Institute.  Controls include the state unemployment rate, per capita income, the state 
beer tax, and indicators for marijuana decriminalization, BAC 0.08, administrative license revocation, and 
Zero Tolerance.  Regressions are weighted using state populations.  Standard errors, corrected for 
clustering at the state level, are in parentheses.    
 